A Randomized Double Blinded Placebo-Controlled Phase III Trial Comparing Cyclosporine Plus Steroids With or Without Myfortic as Primary Treatment for Extensive Chronic Graft Versus Host Disease

Trial Profile

A Randomized Double Blinded Placebo-Controlled Phase III Trial Comparing Cyclosporine Plus Steroids With or Without Myfortic as Primary Treatment for Extensive Chronic Graft Versus Host Disease

Discontinued
Phase of Trial: Phase III

Latest Information Update: 06 May 2014

At a glance

  • Drugs Mycophenolate sodium (Primary) ; Ciclosporin; Prednisone
  • Indications Graft-versus-host disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Sep 2009 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 01 Sep 2009 Actual patient number (34) added as reported by ClinicalTrials.gov.
    • 01 Sep 2009 Planned end date changed from 1 Sep 2008 to 1 Nov 2010 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top